Copyright Reports & Markets. All rights reserved.

Global Tinea Pedis Treatment Market Research Report 2019

Request for Sample of this report
Buy now

Table of Contents

    Executive Summary

      1 Tinea Pedis Treatment Market Overview

      • 1.1 Product Overview and Scope of Tinea Pedis Treatment
      • 1.2 Tinea Pedis Treatment Segment by Type
        • 1.2.1 Global Tinea Pedis Treatment Production Growth Rate Comparison by Type (2014-2025)
        • 1.2.2 Interdigital
        • 1.2.3 Vesicular
      • 1.3 Tinea Pedis Treatment Segment by Application
        • 1.3.1 Tinea Pedis Treatment Consumption Comparison by Application (2014-2025)
        • 1.3.2 Hospital Pharmacies
        • 1.3.3 Retail Pharmacies
        • 1.3.4 Online Pharmacies
        • 1.3.5 Drug Stores
        • 1.3.6 Others
      • 1.4 Global Tinea Pedis Treatment Market by Region
        • 1.4.1 Global Tinea Pedis Treatment Market Size Region
        • 1.4.2 North America Status and Prospect (2014-2025)
        • 1.4.3 Europe Status and Prospect (2014-2025)
        • 1.4.4 China Status and Prospect (2014-2025)
        • 1.4.5 Japan Status and Prospect (2014-2025)
      • 1.5 Global Tinea Pedis Treatment Market Size
        • 1.5.1 Global Tinea Pedis Treatment Revenue (2014-2025)
        • 1.5.2 Global Tinea Pedis Treatment Production (2014-2025)

      2 Global Tinea Pedis Treatment Market Competition by Manufacturers

      • 2.1 Global Tinea Pedis Treatment Production Market Share by Manufacturers (2014-2019)
      • 2.2 Global Tinea Pedis Treatment Revenue Share by Manufacturers (2014-2019)
      • 2.3 Global Tinea Pedis Treatment Average Price by Manufacturers (2014-2019)
      • 2.4 Manufacturers Tinea Pedis Treatment Production Sites, Area Served, Product Types
      • 2.5 Tinea Pedis Treatment Market Competitive Situation and Trends
        • 2.5.1 Tinea Pedis Treatment Market Concentration Rate
        • 2.5.2 Tinea Pedis Treatment Market Share of Top 3 and Top 5 Manufacturers
        • 2.5.3 Mergers & Acquisitions, Expansion

      3 Global Tinea Pedis Treatment Production Market Share by Regions

      • 3.1 Global Tinea Pedis Treatment Production Market Share by Regions
      • 3.2 Global Tinea Pedis Treatment Revenue Market Share by Regions (2014-2019)
      • 3.3 Global Tinea Pedis Treatment Production, Revenue, Price and Gross Margin (2014-2019)
      • 3.4 North America Tinea Pedis Treatment Production
        • 3.4.1 North America Tinea Pedis Treatment Production Growth Rate (2014-2019)
        • 3.4.2 North America Tinea Pedis Treatment Production, Revenue, Price and Gross Margin (2014-2019)
      • 3.5 Europe Tinea Pedis Treatment Production
        • 3.5.1 Europe Tinea Pedis Treatment Production Growth Rate (2014-2019)
        • 3.5.2 Europe Tinea Pedis Treatment Production, Revenue, Price and Gross Margin (2014-2019)
      • 3.6 China Tinea Pedis Treatment Production (2014-2019)
        • 3.6.1 China Tinea Pedis Treatment Production Growth Rate (2014-2019)
        • 3.6.2 China Tinea Pedis Treatment Production, Revenue, Price and Gross Margin (2014-2019)
      • 3.7 Japan Tinea Pedis Treatment Production (2014-2019)
        • 3.7.1 Japan Tinea Pedis Treatment Production Growth Rate (2014-2019)
        • 3.7.2 Japan Tinea Pedis Treatment Production, Revenue, Price and Gross Margin (2014-2019)

      4 Global Tinea Pedis Treatment Consumption by Regions

      • 4.1 Global Tinea Pedis Treatment Consumption by Regions
      • 4.2 North America Tinea Pedis Treatment Consumption (2014-2019)
      • 4.3 Europe Tinea Pedis Treatment Consumption (2014-2019)
      • 4.4 China Tinea Pedis Treatment Consumption (2014-2019)
      • 4.5 Japan Tinea Pedis Treatment Consumption (2014-2019)

      5 Global Tinea Pedis Treatment Production, Revenue, Price Trend by Type

      • 5.1 Global Tinea Pedis Treatment Production Market Share by Type (2014-2019)
      • 5.2 Global Tinea Pedis Treatment Revenue Market Share by Type (2014-2019)
      • 5.3 Global Tinea Pedis Treatment Price by Type (2014-2019)
      • 5.4 Global Tinea Pedis Treatment Production Growth by Type (2014-2019)

      6 Global Tinea Pedis Treatment Market Analysis by Applications

      • 6.1 Global Tinea Pedis Treatment Consumption Market Share by Application (2014-2019)
      • 6.2 Global Tinea Pedis Treatment Consumption Growth Rate by Application (2014-2019)

      7 Company Profiles and Key Figures in Tinea Pedis Treatment Business

      • 7.1 GSK
        • 7.1.1 GSK Tinea Pedis Treatment Production Sites and Area Served
        • 7.1.2 Tinea Pedis Treatment Product Introduction, Application and Specification
        • 7.1.3 GSK Tinea Pedis Treatment Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.1.4 Main Business and Markets Served
      • 7.2 Exeltis USA
        • 7.2.1 Exeltis USA Tinea Pedis Treatment Production Sites and Area Served
        • 7.2.2 Tinea Pedis Treatment Product Introduction, Application and Specification
        • 7.2.3 Exeltis USA Tinea Pedis Treatment Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.2.4 Main Business and Markets Served
      • 7.3 Valeant
        • 7.3.1 Valeant Tinea Pedis Treatment Production Sites and Area Served
        • 7.3.2 Tinea Pedis Treatment Product Introduction, Application and Specification
        • 7.3.3 Valeant Tinea Pedis Treatment Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.3.4 Main Business and Markets Served
      • 7.4 Incyte
        • 7.4.1 Incyte Tinea Pedis Treatment Production Sites and Area Served
        • 7.4.2 Tinea Pedis Treatment Product Introduction, Application and Specification
        • 7.4.3 Incyte Tinea Pedis Treatment Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.4.4 Main Business and Markets Served
      • 7.5 Celgene
        • 7.5.1 Celgene Tinea Pedis Treatment Production Sites and Area Served
        • 7.5.2 Tinea Pedis Treatment Product Introduction, Application and Specification
        • 7.5.3 Celgene Tinea Pedis Treatment Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.5.4 Main Business and Markets Served
      • 7.6 Hisamitsu Pharmaceutical
        • 7.6.1 Hisamitsu Pharmaceutical Tinea Pedis Treatment Production Sites and Area Served
        • 7.6.2 Tinea Pedis Treatment Product Introduction, Application and Specification
        • 7.6.3 Hisamitsu Pharmaceutical Tinea Pedis Treatment Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.6.4 Main Business and Markets Served
      • 7.7 NovaBiotics
        • 7.7.1 NovaBiotics Tinea Pedis Treatment Production Sites and Area Served
        • 7.7.2 Tinea Pedis Treatment Product Introduction, Application and Specification
        • 7.7.3 NovaBiotics Tinea Pedis Treatment Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.7.4 Main Business and Markets Served
      • 7.8 Elorac
        • 7.8.1 Elorac Tinea Pedis Treatment Production Sites and Area Served
        • 7.8.2 Tinea Pedis Treatment Product Introduction, Application and Specification
        • 7.8.3 Elorac Tinea Pedis Treatment Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.8.4 Main Business and Markets Served
      • 7.9 F. Hoffmann-La Roche
        • 7.9.1 F. Hoffmann-La Roche Tinea Pedis Treatment Production Sites and Area Served
        • 7.9.2 Tinea Pedis Treatment Product Introduction, Application and Specification
        • 7.9.3 F. Hoffmann-La Roche Tinea Pedis Treatment Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.9.4 Main Business and Markets Served
      • 7.10 Sanofi
        • 7.10.1 Sanofi Tinea Pedis Treatment Production Sites and Area Served
        • 7.10.2 Tinea Pedis Treatment Product Introduction, Application and Specification
        • 7.10.3 Sanofi Tinea Pedis Treatment Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.10.4 Main Business and Markets Served
      • 7.11 Teva Pharmaceutical

      8 Tinea Pedis Treatment Manufacturing Cost Analysis

      • 8.1 Tinea Pedis Treatment Key Raw Materials Analysis
        • 8.1.1 Key Raw Materials
        • 8.1.2 Price Trend of Key Raw Materials
        • 8.1.3 Key Suppliers of Raw Materials
      • 8.2 Proportion of Manufacturing Cost Structure
      • 8.3 Manufacturing Process Analysis of Tinea Pedis Treatment
      • 8.4 Tinea Pedis Treatment Industrial Chain Analysis

      9 Marketing Channel, Distributors and Customers

      • 9.1 Marketing Channel
        • 9.1.1 Direct Marketing
        • 9.1.2 Indirect Marketing
      • 9.2 Tinea Pedis Treatment Distributors List
      • 9.3 Tinea Pedis Treatment Customers

      10 Market Dynamics

      • 10.1 Market Trends
      • 10.2 Opportunities
      • 10.3 Market Drivers
      • 10.4 Challenges
      • 10.5 Influence Factors

      11 Global Tinea Pedis Treatment Market Forecast

      • 11.1 Global Tinea Pedis Treatment Production, Revenue Forecast
        • 11.1.1 Global Tinea Pedis Treatment Production Growth Rate Forecast (2019-2025)
        • 11.1.2 Global Tinea Pedis Treatment Revenue and Growth Rate Forecast (2019-2025)
        • 11.1.3 Global Tinea Pedis Treatment Price and Trend Forecast (2019-2025)
      • 11.2 Global Tinea Pedis Treatment Production Forecast by Regions (2019-2025)
        • 11.2.1 North America Tinea Pedis Treatment Production, Revenue Forecast (2019-2025)
        • 11.2.2 Europe Tinea Pedis Treatment Production, Revenue Forecast (2019-2025)
        • 11.2.3 China Tinea Pedis Treatment Production, Revenue Forecast (2019-2025)
        • 11.2.4 Japan Tinea Pedis Treatment Production, Revenue Forecast (2019-2025)
      • 11.3 Global Tinea Pedis Treatment Consumption Forecast by Regions (2019-2025)
        • 11.3.1 North America Tinea Pedis Treatment Consumption Forecast (2019-2025)
        • 11.3.2 Europe Tinea Pedis Treatment Consumption Forecast (2019-2025)
        • 11.3.3 China Tinea Pedis Treatment Consumption Forecast (2019-2025)
        • 11.3.4 Japan Tinea Pedis Treatment Consumption Forecast (2019-2025)
      • 11.4 Global Tinea Pedis Treatment Production, Revenue and Price Forecast by Type (2019-2025)
      • 11.5 Global Tinea Pedis Treatment Consumption Forecast by Application (2019-2025)

      12 Research Findings and Conclusion

        13 Methodology and Data Source

        • 13.1 Methodology/Research Approach
          • 13.1.1 Research Programs/Design
          • 13.1.2 Market Size Estimation
          • 13.1.3 Market Breakdown and Data Triangulation
        • 13.2 Data Source
          • 13.2.1 Secondary Sources
          • 13.2.2 Primary Sources
        • 13.3 Author List

        Tinea infections are fungal infections caused by T rubrum, Trichophyton mentagrophytes and Epidermophyton floccosum. This dermatophyte fungus thrives in humid conditions. The clinical features of tinea pedis include patchy and dry scaling on foot and presence of blisters or pustules on feet and between toes.
        The rising prevalence of diabetes that is fueling the incidence of tinea pedis is one of the primary growth factors for this market. There is an increased prevalence of diabetes across the globe due to high levels of sugar in the blood streams and this results in numerous health issues. Diabetes reduces the quality of life, increases the risk of obesity, and early death. People with diabetes tend to be more resistant to antifungal treatment regimens due to high blood glucose levels which increases the chances  of fungal growth. Consequently, diabetes patients tend to have a high risk of foot ulcerations and infections that can lead to tinea pedis or onychomycosis resulting in the need for the effective treatment of this infection.
        North America is the largest and reflects a high market attractiveness index. APEJ is the second largest regional market for tinea pedis treatment in terms of valuation and is the fastest growing region with a high CAGR of 6.1% recorded during the period of forecast.

        The global Tinea Pedis Treatment market is valued at xx million US$ in 2018 is expected to reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
        This report focuses on Tinea Pedis Treatment volume and value at global level, regional level and company level. From a global perspective, this report represents overall Tinea Pedis Treatment market size by analyzing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan.
        At company level, this report focuses on the production capacity, ex-factory price, revenue and market share for each manufacturer covered in this report.

        The following manufacturers are covered:
        GSK
        Exeltis USA
        Valeant
        Incyte
        Celgene
        Hisamitsu Pharmaceutical
        NovaBiotics
        Elorac
        F. Hoffmann-La Roche
        Sanofi
        Teva Pharmaceutical

        Segment by Regions
        North America
        Europe
        China
        Japan

        Segment by Type
        Interdigital
        Vesicular

        Segment by Application
        Hospital Pharmacies
        Retail Pharmacies
        Online Pharmacies
        Drug Stores
        Others

        Buy now